Use of pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products

Current effective version

PDF iconAdopted guideline

Current version - see below

Reference numberCHMP/594085/2016
Published26/07/2016
Effective from01/02/2017
KeywordsEpidemiologic cut-off value, exposure-response relationship, minimal inhibitory concentration, pharmacokinetic-pharmacodynamic index, magnitude, target, probability of target attainment, wild-type distribution
DescriptionThis document addresses the use of pharmacokinetic-pharmacodynamic analyses to identify potentially eficacious dose regimens of antibacterial agents. It applies also to antimycobacterial and antifungal agents.


Document history

Revision 1
Current version

PDF iconAdopted guideline

PDF iconDraft guideline

PDF iconOverview of comments

PDF iconConcept paper

In operation: 01/02/2017


Published: 28/02/2014

Published: 18/10/2016

First version PDF iconPoints to consider Published: 27/07/2000


Related content


How useful was this page?

Add your rating